Direct-to-Consumer Laboratory Testing Market Size to Worth US$ 32.6 Billion by 2030

According to the new research report published by Precedence Research, titled “Direct-to-Consumer Laboratory Testing Market (By Product: Medical Genetic Laboratory Testing, Routine Clinical Laboratory Testing; By Test Type: Genetic Testing, COVID-19, Cancer, Diabetes Testing, Disease Risk Assessment Testing, Sexually Transmitted Disease Testing, Routine Testing, Complete Blood Count, CNS-related/Neurological Disease, Thyroid Stimulating Hormone Testing, Other; By Sample Type; By End User) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022-2030”, the global direct-to-consumer laboratory testing market size is expected to be worth around US$ 32.6 billion by 2030 and is poised to record a yearly growth rate of 34.72% from 2022 to 2030. The study investigates several elements and their consequences on the growth of the all-wheel drive market.

This report focuses on direct-to-consumer laboratory testing market volume and value at the global level, regional level and company level. From a global perspective, this report represents the overall direct-to-consumer laboratory testing market size by analysing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, the Middle East & Africa, Latin America, etc.

 The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Download a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2313

The study also provides important advancements in organic and inorganic growth strategies in the worldwide direct-to-consumer laboratory testing market. A lot of corporations are prioritizing new launches, product approvals, and other business expansion techniques. In addition, the report offers profiles of direct-to-consumer laboratory testing market firms and market strategies. Furthermore, the research focuses on top industry participants, providing information such as company profiles, components and services offered, recent financial data, and key developments.

Direct-to-Consumer Laboratory Testing Market Report Scope

Also read: Flavors and Fragrances Market Size to Worth US$ 44.18 Billion by 2030

Market Key Players

Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the direct-to-consumer laboratory testing market.

Some of the prominent players in the direct-to-consumer laboratory testing market include:

• 23andMe, Inc
• Ambry Genetics Corp.
• Ancestry.com LLC
• Any Lab Test Now, Inc.
• Color Genomics, Inc
• Counsyl, Inc.
• DanteLabs Inc.
• Direct Laboratory Services, LLC
• Eastern Biotech & Life Sciences
• EasyDNA
• EverlyWell, Inc.,
• Full Genomes Corporation, Inc.
• Gene by Gene, Ltd.
• Genecodebook Oy
• Genesis Healthcare Co.
• Genetrainer
• GHC Genetics UK
• HealthCheckUSA
• Home Access Health Corporation
• International Biosciences
• Laboratory Corporation of America Holdings
• LetsGetChecked, Inc.
• Mapmygenome India Limited
• Medichecks.com Ltd.
• MyHeritage Ltd.
• MyMedLab, Inc.,
• Myriad Genetics, Inc.
• Natera, Inc
• OME Care
• Pathway Genomics
• Pixel by LabCorp,
• Positive Bioscience
• Quest Diagnostics Incorporated,
• Request A Test, Ltd.
• Shuwen Biotech Co. Ltd.
• Sonora Quest Laboratories,
• Thryve Inc
• Ulta Lab Tests, LLC,
• Veritas Genetics
• Vitagene, Inc.
• Walk-In Lab, LLC.,
• WellnessFX, Inc.
• Xcode Life Sciences

Direct-to-Consumer Laboratory Testing Market Segmentations 

By Product

• Medical Genetic Laboratory Testing
• Routine Clinical Laboratory Testing

By Test Type

• Genetic Testing
• COVID-19
• Cancer
• Diabetes Testing
• Disease Risk Assessment Testing
• Sexually Transmitted Disease Testing
• Routine Testing
• Complete Blood Count
• CNS-related/Neurological Disease
• Thyroid Stimulating Hormone Testing
• Other

By Sample Type

• Blood
• Urine
• Saliva
• Others

By End User

• Hospitals
• Diagnostic Centers
• Blood Banks
• Home Care
• Others

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)

Report Objectives 

• To define, segment, and project the global market size for direct-to-consumer laboratory testing market
• To understand the structure of the market by identifying its various sub-segments
• To provide detailed information about the key factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
• To analyze the micro-markets, with respect to individual growth trends, future prospects, and their contributions to the total market
• To project the size of the market and its submarkets, in terms of value, with respect to global. (along with their respective key countries)
• To profile key players and comprehensively analyze their core competencies
• To understand the competitive landscape and identify major growth strategies adopted by players across the globe.
• To analyze the competitive developments such as expansions & investments, new product launches, mergers & acquisitions, joint ventures, and agreements 

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Direct-To-Consumer Laboratory Testing Market 

5.1. COVID-19 Landscape: Direct-To-Consumer Laboratory Testing Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Direct-To-Consumer Laboratory Testing Market, By Product

8.1. Direct-To-Consumer Laboratory Testing Market, by Product, 2022-2030

8.1.1. Medical Genetic Laboratory Testing

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Routine Clinical Laboratory Testing

8.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Direct-To-Consumer Laboratory Testing Market, By Test Type

9.1. Direct-To-Consumer Laboratory Testing Market, by Test Type, 2022-2030

9.1.1. Genetic Testing

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. COVID-19

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Cancer

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Diabetes Testing

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Disease Risk Assessment Testing

9.1.5.1. Market Revenue and Forecast (2017-2030)

9.1.6. Sexually Transmitted Disease Testing

9.1.6.1. Market Revenue and Forecast (2017-2030)

9.1.7. Routine Testing

9.1.7.1. Market Revenue and Forecast (2017-2030)

9.1.8. Complete Blood Count

9.1.8.1. Market Revenue and Forecast (2017-2030)

9.1.9. CNS-related/Neurological Disease

9.1.9.1. Market Revenue and Forecast (2017-2030)

9.1.10. Thyroid Stimulating Hormone Testing

9.1.10.1. Market Revenue and Forecast (2017-2030)

9.1.11. Other

9.1.11.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Direct-To-Consumer Laboratory Testing Market, By Sample Type 

10.1. Direct-To-Consumer Laboratory Testing Market, by Sample Type, 2022-2030

10.1.1. Blood

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Urine

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Saliva

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Others

10.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Direct-To-Consumer Laboratory Testing Market, By End User 

11.1. Direct-To-Consumer Laboratory Testing Market, by End User, 2022-2030

11.1.1. Hospitals

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Diagnostic Centers

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Blood Banks

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Home Care

11.1.4.1. Market Revenue and Forecast (2017-2030)

11.1.5. Others

11.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Direct-To-Consumer Laboratory Testing Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product (2017-2030)

12.1.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.1.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.1.4. Market Revenue and Forecast, by End User (2017-2030)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.1.5.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.1.5.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.1.5.4. Market Revenue and Forecast, by End User (2017-2030)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.1.6.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.1.6.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.1.6.4. Market Revenue and Forecast, by End User (2017-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.2.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.2.4. Market Revenue and Forecast, by End User (2017-2030)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.5.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.2.5.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.2.5.4. Market Revenue and Forecast, by End User (2017-2030)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.6.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.2.6.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.2.6.4. Market Revenue and Forecast, by End User (2017-2030)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.7.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.2.7.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.2.7.4. Market Revenue and Forecast, by End User (2017-2030)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.8.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.2.8.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.2.8.4. Market Revenue and Forecast, by End User (2017-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.3.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.3.4. Market Revenue and Forecast, by End User (2017-2030)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.5.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.3.5.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.3.5.4. Market Revenue and Forecast, by End User (2017-2030)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.6.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.3.6.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.3.6.4. Market Revenue and Forecast, by End User (2017-2030)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.7.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.3.7.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.3.7.4. Market Revenue and Forecast, by End User (2017-2030)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.8.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.3.8.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.3.8.4. Market Revenue and Forecast, by End User (2017-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.4.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.4.4. Market Revenue and Forecast, by End User (2017-2030)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.5.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.4.5.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.4.5.4. Market Revenue and Forecast, by End User (2017-2030)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.6.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.4.6.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.4.6.4. Market Revenue and Forecast, by End User (2017-2030)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.7.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.4.7.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.4.7.4. Market Revenue and Forecast, by End User (2017-2030)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.8.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.4.8.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.4.8.4. Market Revenue and Forecast, by End User (2017-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.5.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.5.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.5.4. Market Revenue and Forecast, by End User (2017-2030)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.5.5.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.5.5.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.5.5.4. Market Revenue and Forecast, by End User (2017-2030)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.5.6.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.5.6.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.5.6.4. Market Revenue and Forecast, by End User (2017-2030)

Chapter 13. Company Profiles

13.1. 23andMe, Inc

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Ambry Genetics Corp.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Ancestry.com LLC

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Any Lab Test Now, Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Color Genomics, Inc

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Counsyl, Inc.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. DanteLabs Inc.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Direct Laboratory Services, LLC

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Eastern Biotech & Life Sciences

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. EasyDNA

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Why should you invest in this report?

If you are aiming to enter the global direct-to-consumer laboratory testing market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for direct-to-consumer laboratory testing are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

 

---